Bio-Rad Laboratories is in talks to combine with fellow life-sciences firm Qiagen in a deal worth more than $10 billion, people familiar with the matter say
Bio-Rad Laboratories Inc. is in talks to combine with fellow life-sciences company Qiagen NV in a deal that would be worth more than $10 billion, according to people familiar with the matter.
The talks have been going on for a while but any agreement isn’t likely for another few weeks or more—and there may not be one.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
WSJ News Exclusive | CEO of Biotech Lobbying Group BIO on Leave Amid Clash Over DirectionDr. Michelle McMurry-Heath is on leave amid dissent within BIO, the biotechnology industry’s top lobbying group, about its direction and concern about its results, according to people familiar with the group.
Lire la suite »
WSJ News Exclusive | CEO of Biotech Lobbying Group BIO on Leave Amid Clash Over DirectionDr. Michelle McMurry-Heath is on leave amid dissent within BIO, the biotechnology industry’s top lobbying group, about its direction and concern about its results, according to people familiar with the group.
Lire la suite »
WSJ News Exclusive | BAE, U.S. in Talks to Restart M777 Howitzer Production After Ukraine SuccessArms maker BAE said it was considering restarting production of the M777 howitzer, as the big gun’s performance on Ukrainian battlefields revives interest in the weapon
Lire la suite »